toxylact: a06ab57 cascara combinations

The first professional lActological database in the word

ATC class A06AB57 comprises medicinal products containing cascara (Rhamnus purshiana / Rhamnus frangula) in combination with other laxative or non‑laxative ingredients, used as contact laxatives for short‑term relief of constipation.medpedia.framar+2

Pharmacological class and composition

Cascara combinations are classified within the ATC system as A06AB57 (digestive tract and metabolism → laxatives → contact laxatives → cascara, combinations).atcddd.fhi+2
The cascara component consists of dried and aged bark from buckthorn species such as Rhamnus purshiana and Rhamnus frangula, which contains anthraquinone (anthranoid) glycosides (e.g. cascarosides A–D, aloe‑emodin derivatives) responsible for the laxative effect.sciencedirect+2youtubemedpedia.framar
Finished medicinal products in this class combine cascara with other contact, osmotic or bulking laxatives, or with additional excipients and vitamins, although specific combination partners are product‑dependent and not standardized by the ATC code itself.atcddd.fhi+4

Mechanism of action and therapeutic use

Cascara anthraquinone glycosides are metabolized by colonic bacteria to active aglycones that stimulate enteric nerves, increasing colonic motility and reducing water and electrolyte absorption, leading to softer stools and accelerated transit (contact laxative effect).webmd+1youtubesciencedirect
In combinations, the overall pharmacodynamic effect is additive or synergistic with other laxatives, but still aimed at short‑term treatment of occasional or chronic constipation and facilitation of defecation.peoplespharmacy+3
Clinical use should be restricted to brief courses, typically a few days, because prolonged exposure to stimulant laxatives increases the risk of dependence, electrolyte imbalance and colonic atony.youtubemedpedia.framar+3

Adverse effects, contraindications and precautions

Common adverse reactions to cascara‑containing products include abdominal cramps, colicky pain, diarrhea and, with repeated dosing, benign darkening of urine due to anthranoid metabolites.medpedia.framar+3youtube
Chronic or high‑dose use may cause hypokalemia and other electrolyte disturbances, dehydration, secondary constipation due to colonic atony, and in rare cases liver injury has been reported with cascara sagrada.sciencedirect+2youtubemedpedia.framar
Contraindications include intestinal obstruction, acute abdominal conditions, severely dilated or structurally damaged bowel, and known hypersensitivity to cascara or to any of the combination components; ingestion of the plant fruits is discouraged due to higher toxicity.healthlibrary.brighamandwomens+3
Cascara combinations should not be used as primary treatment in inflammatory bowel disease, severe dehydration, marked electrolyte imbalance, or in patients with unexplained abdominal pain, and they must not be used for weight control.webmd+2

Pregnancy, lactation and toxicological‑lactological notes

Use of cascara‑containing medicinal products during pregnancy is generally not recommended, because stimulant laxatives can provoke strong colonic contractions and safety data are limited; other laxatives with better documented safety profiles are preferred.peoplespharmacy+2
Anthranoid derivatives from cascara can pass into breast milk in small amounts, and there are old reports of transient diarrhea in breastfed infants exposed via maternal intake, although documentation is limited and inconsistent.e-lactation+2
Some expert sources classify cascara as usually compatible with breastfeeding but advise follow‑up of the infant, while other clinical references recommend avoiding cascara during lactation because of the potential risk of loose stools in the breastfed child.e-lactation+1
From a toxicological‑lactological perspective, cascara combinations should be reserved for situations where non‑stimulant laxatives are unsuitable, used at the lowest effective dose for the shortest duration, and avoided when the breastfed infant has diarrhea, prematurity or other gastrointestinal vulnerability.nhs+5

Dosage and clinical monitoring

Product‑specific dosing is determined by the content of anthraquinone derivatives and co‑formulated laxatives, but typical adult doses of cascara sagrada supply approximately 20–70 mg of anthraquinones per day in monocomponent preparations; combinations are titrated to achieve one soft bowel movement per day without diarrhea.youtubewebmd+1
Before initiating cascara combinations, medical consultation is recommended, especially in patients with chronic constipation, multiple comorbidities, concomitant diuretic or cardiac glycoside therapy, and in pregnant or breastfeeding women.healthlibrary.brighamandwomens+3
Clinical monitoring should focus on stool pattern, abdominal symptoms, hydration status and electrolytes (particularly potassium) during use, and therapy should be discontinued promptly if abdominal pain, persistent diarrhea or signs of liver dysfunction occur.medpedia.framar+3youtube

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.